Elite Financial’s Johnson & Johnson JNJ Stock Holding History

Elite Financial’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-484	Closed	-$80K	–	81
2025 Q1	$80K	Buy	+484	New	+$75.7K	0.04%	71

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Elite Financial's JNJ Position: Q2 2025 in Review

Elite Financial sold out of Johnson & Johnson (JNJ) in Q2 2025, closing a stake of 484 shares — an estimated $80K sold.

Elite Financial first reported a position in JNJ in Q1 2025 and held it in 1 quarter. The position peaked at $80K in Q1 2025. 4,083 funds tracked by Wall St. Rank hold JNJ as of Q2 2025.

Elite Financial reported no remaining Johnson & Johnson position as of Q2 2025 after selling out during the quarter.
Elite Financial sold 484 Johnson & Johnson shares in Q2 2025, an estimated $80K.
Elite Financial first reported a position in Johnson & Johnson in Q1 2025 and held it in 1 quarter.
Elite Financial's Johnson & Johnson position peaked at $80K in Q1 2025.
4,083 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2025.

Based on Elite Financial's 13F filing for Q2 2025, filed 11 Aug 2025.